Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MESA LABORATORIES INC /CO/MLAB · Entity 5221 | Director | September 01, 2022 | September 02, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MESA LABORATORIES INC /CO/
Report date September 01, 2022 · Filed September 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,207 |
Reported balance
After 2022-09-01 transaction · row 1
1 source rowRow 1 · 2022-09-01 · Exercise / conversion · Acquired 431 · Balance 29,207 |
| Restricted Stock Units - 6SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-09-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-09-01 · Other · Disposed 431 · Balance 0 F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2: Vested RSUs for Board of Director services F3: Not applicable |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock
F2: Vested RSUs for Board of Director services
F3: Not applicable
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2022 Filed Sep 2, 2022 16:24 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherRestricted Stock Units - 6 · Derivative | 431 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000035 · primary_doc.xml · derivative · entry 2 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 431 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Vested RSUs for Board of Director services F3 · derivative.expiration_date: Not applicable Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 16:24 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 431 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000035 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 15:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 360 | $0.00 Strike: $142.40 | $0.00 |
DisclosureSEC source: 0001228924-22-000033 · primary_doc.xml · derivative · entry 7 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90 Underlying: Common Stock · 360 shares Expires 2024-04-02 F3 · derivative.exercise_date: 1/5 exercisable on each anniversary date of the 04-02-2018 grant date Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 15:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,000 | $0.00 Strike: $122.66 | $0.00 |
DisclosureSEC source: 0001228924-22-000033 · primary_doc.xml · derivative · entry 6 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450 Underlying: Common Stock · 1,000 shares Expires 2023-04-03 F2 · derivative.exercise_date: 1/5 exercisable on each anniversary date of the 04-03-2017 grant date Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 15:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,320 | $0.00 Strike: $70.56 | $0.00 |
DisclosureSEC source: 0001228924-22-000033 · primary_doc.xml · derivative · entry 5 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,450 Underlying: Common Stock · 1,320 shares Expires 2023-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04-01-2015 grant date Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 15:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 3,692 | $196.12 | $724,075.04 |
DisclosureSEC source: 0001228924-22-000033 · primary_doc.xml · nonDerivative · entry 4 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,776 Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 15:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 360 | $142.40 | $51,264.00 |
DisclosureSEC source: 0001228924-22-000033 · primary_doc.xml · nonDerivative · entry 3 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 15:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,000 | $122.66 | $122,660.00 |
DisclosureSEC source: 0001228924-22-000033 · primary_doc.xml · nonDerivative · entry 2 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 15:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,320 | $70.56 | $93,139.20 |
DisclosureSEC source: 0001228924-22-000033 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 22:17 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Unit - 1 · Derivative | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000013 · primary_doc.xml · derivative · entry 2 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30 Underlying: Common Stock · 30 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 22:17 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000013 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 17:07 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,000 | $0.00 Strike: $97.78 | $0.00 |
DisclosureSEC source: 0001228924-21-000081 · primary_doc.xml · derivative · entry 7 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,770 Underlying: Common Stock · 1,000 shares Expires 2022-04-01 F3 · derivative.exercise_date: 1/5 exercisable on each anniversary date of the 04-01-2016 grant adte Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 17:07 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 120 | $0.00 Strike: $58.51 | $0.00 |
DisclosureSEC source: 0001228924-21-000081 · primary_doc.xml · derivative · entry 6 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,770 Underlying: Common Stock · 120 shares Expires 2022-10-02 F2 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 10-02-2014 grant date Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 17:07 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,200 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001228924-21-000081 · primary_doc.xml · derivative · entry 5 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,890 Underlying: Common Stock · 1,200 shares Expires 2022-04-01 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04-01-2014 grant date Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 17:07 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 2,320 | $310.61 | $720,615.20 |
DisclosureSEC source: 0001228924-21-000081 · primary_doc.xml · nonDerivative · entry 4 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,758 Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 17:07 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,000 | $97.78 | $97,780.00 |
DisclosureSEC source: 0001228924-21-000081 · primary_doc.xml · nonDerivative · entry 3 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 17:07 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 120 | $58.51 | $7,021.20 |
DisclosureSEC source: 0001228924-21-000081 · primary_doc.xml · nonDerivative · entry 2 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 17:07 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,200 | $89.70 | $107,640.00 |
DisclosureSEC source: 0001228924-21-000081 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 21:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 6 · Derivative | 431 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000066 · primary_doc.xml · derivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431 Underlying: Common Stock · 431 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on September 1, 2022 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2021 Filed Aug 16, 2021 17:44 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 5 · Derivative | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000052 · primary_doc.xml · derivative · entry 2 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 308 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted Stock Units that vested 100% on August 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2021 Filed Aug 16, 2021 17:44 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000052 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 16, 2021 Filed Jul 19, 2021 13:17 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 720 | $282.18 | $203,169.60 |
DisclosureSEC source: 0001228924-21-000047 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,450 F1 · kind: Sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on December 3, 2020 Read SEC document |
| June 16, 2021 Filed Jun 16, 2021 22:40 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 720 | $256.36 | $184,579.20 |
DisclosureSEC source: 0001228924-21-000037 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,170 F1 · kind: Sale reported on the Form 4 was effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on December 3, 2020 Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 18:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 4 · Derivative | 265 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000029 · primary_doc.xml · derivative · entry 4 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 265 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: Represents Restricted Stock Units granted for the conversion of cash compensation for Board of Director services for the twelve months ended June 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 18:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units -1 · Derivative | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000029 · primary_doc.xml · derivative · entry 3 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60 Underlying: Common Stock · 30 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted Stock Units that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 18:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 265 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000029 · primary_doc.xml · nonDerivative · entry 2 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 18:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000029 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2021 Filed May 18, 2021 16:49 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 720 | $244.25 | $175,860.00 |
DisclosureSEC source: 0001228924-21-000019 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,595 F1 · kind: Sale reported on the Form 4 was effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on December 3, 2020 Read SEC document |
| April 16, 2021 Filed Apr 19, 2021 14:52 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | SaleCommon Stock | 720 | $253.77 | $182,714.40 |
DisclosureSEC source: 0001228924-21-000016 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,315 F1 · kind: Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on December 3, 2020 Read SEC document |
| March 16, 2021 Filed Mar 16, 2021 23:57 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 720 | $269.48 | $194,025.60 |
DisclosureSEC source: 0001228924-21-000012 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,035 F1 · kind: Sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on December 3, 2020 Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 15:44 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 3,600 | $281.52 | $1,013,472.00 |
DisclosureSEC source: 0001228924-21-000007 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,755 F1 · kind: Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on December 3, 2020 Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 16:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 3 · Derivative | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000037 · primary_doc.xml · derivative · entry 3 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 477 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: RSUs that vested on November 15, 2020 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 16:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Unit - 5 · Derivative | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000037 · primary_doc.xml · derivative · entry 2 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308 Underlying: Common Stock · 308 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on August 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 16:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000037 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Represents common stock from RSUs that vested on November 15, 2020 Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:48 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 200 | $0.00 Strike: $51.85 | $0.00 |
DisclosureSEC source: 0001228924-20-000036 · primary_doc.xml · derivative · entry 7 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,090 Underlying: Common Stock · 200 shares Expires 2023-04-01 F3 · derivative.exercise_date: 1/4 exercisable on each anniversary date of the 4-1-13 grant date Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:48 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,000 | $0.00 Strike: $50.50 | $0.00 |
DisclosureSEC source: 0001228924-20-000036 · primary_doc.xml · derivative · entry 6 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,290 Underlying: Common Stock · 1,000 shares Expires 2022-04-02 F2 · derivative.exercise_date: 1/4 exercisable on each anniversary date of the 4-2-12 grant date Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:48 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 850 | $0.00 Strike: $29.20 | $0.00 |
DisclosureSEC source: 0001228924-20-000036 · primary_doc.xml · derivative · entry 5 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,290 Underlying: Common Stock · 850 shares Expires 2021-04-06 F1 · derivative.exercise_date: 1/4 exercisable on each anniversary date of the 4-6-11 grant date Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:48 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 2,050 | $274.30 | $562,315.00 |
DisclosureSEC source: 0001228924-20-000036 · primary_doc.xml · nonDerivative · entry 4 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,878 Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:48 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 200 | $51.85 | $10,370.00 |
DisclosureSEC source: 0001228924-20-000036 · primary_doc.xml · nonDerivative · entry 3 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:48 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,000 | $50.50 | $50,500.00 |
DisclosureSEC source: 0001228924-20-000036 · primary_doc.xml · nonDerivative · entry 2 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:48 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 850 | $29.20 | $24,820.00 |
DisclosureSEC source: 0001228924-20-000036 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2020 Filed Nov 13, 2020 22:21 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 800 | $0.00 Strike: $51.85 | $0.00 |
DisclosureSEC source: 0001437749-20-023862 · rdgdoc.xml · derivative · entry 5 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,090 Underlying: Common Stock · 800 shares Expires 2023-04-01 F2 · derivative.exercise_date: 1/4 exercisable on each anniversary date of the 4/1/13 grant date Read SEC document |
| November 12, 2020 Filed Nov 13, 2020 22:21 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 150 | $0.00 Strike: $29.30 | $0.00 |
DisclosureSEC source: 0001437749-20-023862 · rdgdoc.xml · derivative · entry 4 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,890 Underlying: Common Stock · 150 shares Expires 2021-04-06 F1 · derivative.exercise_date: 1/4 exercisable on each anniversary date of the 4/06/11 grant date Read SEC document |
| November 12, 2020 Filed Nov 13, 2020 22:21 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 950 | $273.77 | $260,081.50 |
DisclosureSEC source: 0001437749-20-023862 · rdgdoc.xml · nonDerivative · entry 3 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,878 Read SEC document |
| November 12, 2020 Filed Nov 13, 2020 22:21 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 800 | $51.85 | $41,480.00 |
DisclosureSEC source: 0001437749-20-023862 · rdgdoc.xml · nonDerivative · entry 2 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2020 Filed Nov 13, 2020 22:21 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 150 | $29.20 | $4,380.00 |
DisclosureSEC source: 0001437749-20-023862 · rdgdoc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 23:33 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 4 · Derivative | 265 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000013 · primary_doc.xml · derivative · entry 3 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265 Underlying: Common Stock · 265 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · shares: Represents RSUs granted for the conversion of cash compensation for Board of Director services for the next 12 months F5 · derivative.exercise_date: RSUs that cliff vest on June 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 23:33 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000013 · primary_doc.xml · derivative · entry 2 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90 Underlying: Common Stock · 30 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 23:33 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000013 · primary_doc.xml · nonDerivative · entry 1 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 00:22 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000054 · primary_doc.xml · nonDerivative · entry 2 GUILLEMIN EVAN · CIK 0001246295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,848 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.